Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2025-12-16 @ 11:13 PM
Study NCT ID:
NCT06264180
Status:
None
Last Update Posted:
2025-09-22 00:00:00
First Post:
2024-01-29 00:00:00
Brief Title:
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Sponsor:
Replimune Inc
Organization:
Replimune Inc.
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Melanoma |
Keywords: